- Forums
- ASX - By Stock
- IBX
- Ann: Imagion announces HREC approval for Phase I study
Ann: Imagion announces HREC approval for Phase I study, page-150
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.001(2.17%) |
Mkt cap ! $2.022M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.7¢ | $294 | 6.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 52082 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 10995 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 52082 | 0.048 |
2 | 10798 | 0.047 |
3 | 145755 | 0.046 |
4 | 122509 | 0.045 |
1 | 165000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 10995 | 1 |
0.055 | 20000 | 1 |
0.060 | 23574 | 2 |
0.063 | 38873 | 1 |
0.070 | 822 | 2 |
Last trade - 10.17am 13/11/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online